Skip to main content
Quest Diagnostics10-Q: Major contract win

Expanded laboratory testing at Fresenius Medical Care dialysis clinics across the United States

Source: Autobound Signal API · 69 signals tracked for Quest Diagnostics · updated

Get Quest Diagnostics' live signals in Claude or ChatGPT, or by API

AskWhat changed at Quest Diagnostics this week? Use Autobound signals for questdiagnostics.com.

What happened

Quest increased its laboratory testing at U.S. dialysis clinics owned by Fresenius Medical Care, driving significant organic DIS volume growth alongside the Corewell Health relationship.

Source

SEC EDGARApr 22, 2026

Quarterly report (Form 10-Q)

Quest Diagnostics 10-Q for Quarter ended Mar 31, 2026

Filing excerpt

DIS volume increased by 10.9% compared to the prior year period principally driven by organic growth of 10.8%, of which approximately 7% was due to both our new relationship with Corewell Health to provide Collaborative Lab Solutions and increasing our laboratory testing at dialysis clinics owned by Fresenius Medical Care in the United States.

sec.gov/Archives/edgar/data/1022079/000102207926000043/dgx-20260331.htmRead the full source

Other signals in this filing (3)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Major contract win

What this signalsFilings often name leadership changes, deals and spending plans.

Period
Quarter ended Mar 31, 2026
Fiscal year end
03/31
Filed
Apr 22, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Percent
7% (portion of organic volume growth due to relationships with Corewell Health and Fresenius Medical Care)

Details

CIK
1022079
Accession number
0001022079-26-000043
Timeframe
Current quarter
Quarter
Q1
Filing year
2026
Period end date
Mar 31, 2026
Why it matters
Scaling needs
Signal category
Revenue

Topics and mentions

Regions named

  • United States

Extraction

Confidence
High
Relevance
75%
Sentiment
Positive
Detected
Nov 9, 2026
signal_type
sec-10q
signal_subtype
majorContractWin

Use this data

Get every 10-Q signal for Quest Diagnostics and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Quest Diagnostics this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/b362b0ec-e8cd-425b-993c-ffe119a4ac62 returns this record as JSON. POST /v1/companies/enrich returns every signal for questdiagnostics.com.

{
  "signal_id": "b362b0ec-e8cd-425b-993c-ffe119a4ac62",
  "signal_type": "sec-10q",
  "signal_subtype": "majorContractWin",
  "detected_at": "2026-11-09T06:23:56.573+00:00",
  "company": {
    "name": "Quest Diagnostics",
    "domain": "questdiagnostics.com"
  },
  "data": {
    "detail": "Quest increased its laboratory testing at U.S. dialysis clinics owned by Fresenius Medical Care, driving significant organic DIS volume growth alongside the Corewell Health relationship. Sellers of clinical testing logistics and high-volume specimen management tools may find opportunities to support this expanded volume.",
    "metrics": {
      "pct": 0.07,
      "timeframe": "current_quarter",
      "pct_context": "portion of organic volume growth due to relationships with Corewell Health and Fresenius Medical Care"
    },
    "quarter": "Q1",
    "summary": "Expanded laboratory testing at Fresenius Medical Care dialysis clinics across the United States",
    "excerpts": "DIS volume increased by 10.9% compared to the prior year period principally driven by organic growth of 10.8%, of which approximately 7% was due to both our new relationship with Corewell Health to provide Collaborative Lab Solutions and increasing our laboratory testing at dialysis clinics owned by Fresenius Medical Care in the United States.",
    "relevance": 0.75,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1022079/000102207926000043/dgx-20260331.htm",
    "filing_date": "2026-04-22",
    "filing_year": 2026,
    "fiscal_year": 2026,
    "fiscal_year_end": "03/31",
    "period_end_date": "2026-03-31",
    "sales_relevance": "Scaling needs",
    "signal_category": "revenue",
    "regions_mentioned": [
      "United States"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.